I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Li, Jielang
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
A SwinTransformer-Based Segmentation Framework With Self-Su..:
Miao, Dong
;
Li, Jielang
;
Dou, Meng
...
IEEE Journal of Biomedical and Health Informatics. 28 (2024) 1 - p. 403-414 , 2024
Link:
https://doi.org/10.1109/..
?
2
Effectiveness of PD-1 inhibitor-based first-line therapy in..:
Duan, Yichun
;
Li, Jielang
;
Zhou, Shuang
.
Frontiers in Immunology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Favorable response to PD-1 inhibitor plus chemotherapy as f..:
Li, Jielang
;
Ren, Min
;
Bi, Feng
..
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
Capecitabine/cisplatin combined with concurrent intensity-m..:
Li, Jielang
;
Huang, Chen
;
Wang, Xin
..
Clinical and Translational Oncology. 26 (2023) 3 - p. 739-746 , 2023
Link:
https://doi.org/10.1007/..
?
5
Casp8 acts through A20 to inhibit PD‐L1 expression: The mec..:
Zou, Jiahuan
;
Xia, Hongwei
;
Zhang, Chenliang
...
Cancer Science. 112 (2021) 7 - p. 2664-2678 , 2021
Link:
https://doi.org/10.1111/..
?
6
Efficacy of lenvatinib plus pembrolizumab in hepatocellular..:
Li, JieLang
;
Chen, Ting
;
Bi, Feng
.
Tumori Journal. 107 (2021) 6 - p. NP114-NP119 , 2021
Link:
https://doi.org/10.1177/..
?
7
TLR3 activation efficiency by high or low molecular mass po..:
Zhou, Yu
;
Guo, Ming
;
Wang, Xu
...
Innate Immunity. 19 (2012) 2 - p. 184-192 , 2012
Link:
https://doi.org/10.1177/..
?
8
Casp8 acts through A20 to inhibit PD‐L1 expression: The mec..:
Zou, Jiahuan
;
Xia, Hongwei
;
Zhang, Chenliang
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253292/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
TLR3 activation efficiency by high or low molecular mass po..:
Zhou, Yu
;
Guo, Ming
;
Wang, Xu
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942089. , 2012
Link:
http://www.ncbi.nlm.nih...
?
10
Favorable response to PD-1 inhibitor plus chemotherapy as f..:
Jielang Li
;
Min Ren
;
Feng Bi
..
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228653/full. , 2023
Link:
https://doi.org/10.3389/..
?
11
Table_1_Favorable response to PD-1 inhibitor plus chemother..:
Jielang Li
;
Min Ren
;
Feng Bi
..
doi:10.3389/fimmu.2023.1228653.s001. , 2023
Link:
https://doi.org/10.3389/..
?
12
Development of iron supported carbon foam catalyst for Fisc..:
Huang, Jielang
;
Zhu, Zongbo
;
Zhang, Dandan
...
Reaction Kinetics, Mechanisms and Catalysis. 135 (2022) 5 - p. 2457-2473 , 2022
Link:
https://doi.org/10.1007/..
?
13
Physicochemical, conformational properties and ACE-inhibito..:
Guo, Shanguang
;
Ai, Minmin
;
Liu, Jielang
...
LWT. 101 (2019) - p. 469-475 , 2019
Link:
https://doi.org/10.1016/..
1-13